About the Company
We do not have any company description for PSYCHEMEDICS CORP at the moment.
Exchange
OTC
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on PSYCHEMEDICS CORP
Psychemedics Corporation Appoints Shannon Shoemaker as Chief Revenue ...
Psychemedics Corporation is dedicated to providing valuable insights and maintaining the highest standards in substance abuse testing. Investor Relations: Phone: 978-206-8220 Email ...
Don't Buy Psychemedics Corporation (NASDAQ:PMD) For Its Next Dividend ...
Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Psychemedics Corporation (NASDAQ:PMD) is about to trade ex-dividend in the next 4 days ...
Psychemedics Corporation Launches New Ketamine Hair Testing Service
DALLAS, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), a global leader in hair testing, is proud to announce the launch of its new ketamine hair testing solution.
Psychemedics Corporation’s Board of Directors Approves Plan to ...
Psychemedics Corporation is a leading global provider of innovative hair testing for drugs of abuse. With a commitment to accuracy and reliability, the company offers cutting-edge drug testing ...
Psychemedics Corporation Appoints Daniella Mehalik as VP - Finance
ACTON, Mass., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation (PMD), a global leader in hair testing for substance abuse, proudly announces the appointment of Daniella Mehalik as its ...
Psychemedics Releases 2025 Workforce Insights Report
DALLAS, June 16, 2025 (GLOBE NEWSWIRE) -- Psychemedics Corporation, a global leader in hair testing for drugs of abuse, today announced the release of its second annual Workforce Insights Report ...
Is Psychemedics Corp. (PMD) A Good Stock To Buy?
Psychemedics Corp. (NASDAQ:PMD) is not the most popular stock in this group but hedge fund interest is still above average. Our overall hedge fund sentiment score for PMD is 52.3.
Here is What Hedge Funds Think About Psychemedics Corporation (PMD)
Psychemedics Corporation (NASDAQ: PMD) investors should pay attention to an increase in hedge fund interest of late. PMD was in 4 hedge funds’ portfolios at the end of the third quarter of 2019.
Psychemedics Corporation Announces CEO Succession Plan
News provided by Psychemedics Corporation Jul 12, 2023, 5:15 PM ET Brian Hullinger Will Succeed Ray Kubacki as CEO Effective August 17, 2023 Mr. Hullinger Brings 30 Years of Leadership Experience ...
DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching ...
If you have suffered a loss in excess of $100,000 from investment in Psychemedics common stock purchased on or after February 28, 2014 and held through the revelation of negative information ...
Similar Companies
Loading the latest forecasts...